Tag: Migraine
Ubrogepant Administered During Prodrome Beneficial for Migraine
Greater ability to function normally, greater reduction in activity limitations, and greater rate of satisfaction seen with medication
Migraine in Women Not Linked to Risk for Parkinson Disease
No associations seen for migraine with aura, migraine without aura, history of migraine in cohort of middle-aged women
Most Traditional Cardiovascular Risk Factors Not Linked to Migraine
Current smoking, diabetes mellitus, higher fasting glucose level all linked to lower prevalence of migraine in women
Direct CGRP Inhibition Cuts Acne, Rosacea in Patients With Migraine
Significantly reduced rate of acne and rosacea seen in patients treated with CGRPi mAbs versus triptans, topiramate
Atogepant Efficacious for Patients With Chronic Migraine
Reduction seen in monthly headache days, monthly migraine days, and acute medication use days
Targeted Diagnostic Botox Injections Can Identify Trigger Sites for Migraine
Use of Botox as diagnostic model for migraine headache has positive predictive value of 89.5 percent
Use of Acid-Suppression Therapy Linked to Migraine, Severe Headache
Adjusted odds ratios of 1.70, 1.40, and 1.30 seen for proton pump inhibitors, H2 receptor antagonists, and generic antacids, respectively
AAN: Half of Premenopausal Women Have Menstrual Migraines
More than half of women with menstrual migraine report moderate-to-severe disability with their headaches
CVD Risk Increased With Vasomotor Symptoms, History of Migraine
More than twofold risk seen for women with history of migraine, persistent VMS; risk attenuated after adjustment for CVD risk factors
Sleep Quality and Energy Are Precursors of Incident Headache
Average stress and changes in subjective energy levels on previous day linked to incident headache, with different valence for timing of headache
